128 related articles for article (PubMed ID: 27366235)
21. Patient preferences for diabetes treatment attributes and drug classes.
Flood EM; Bell KF; de la Cruz MC; Ginchereau-Sowell FM
Curr Med Res Opin; 2017 Feb; 33(2):261-268. PubMed ID: 27779433
[TBL] [Abstract][Full Text] [Related]
22. Parents' preferences for interventions to improve childhood immunization uptake in northern Nigeria.
Ozawa S; Zhou M; Wonodi C; Chen HH; Bridges JFP
Vaccine; 2018 May; 36(20):2833-2841. PubMed ID: 29661582
[TBL] [Abstract][Full Text] [Related]
23. Preferences for public involvement in health service decisions: a comparison between best-worst scaling and trio-wise stated preference elicitation techniques.
Erdem S; Campbell D
Eur J Health Econ; 2017 Dec; 18(9):1107-1123. PubMed ID: 27942967
[TBL] [Abstract][Full Text] [Related]
24. Preferences of Patients and Pharmacists with Regard to the Management of Drug-Drug Interactions: A Choice-Based Conjoint Analysis.
Heringa M; Floor-Schreudering A; Wouters H; De Smet PAGM; Bouvy ML
Drug Saf; 2018 Feb; 41(2):179-189. PubMed ID: 28965265
[TBL] [Abstract][Full Text] [Related]
25. The Role of Trust in Explaining Food Choice: Combining Choice Experiment and Attribute Best-Worst Scaling.
Yeh CH; Hartmann M; Langen N
Foods; 2020 Jan; 9(1):. PubMed ID: 31947854
[TBL] [Abstract][Full Text] [Related]
26. Patients' preferences and willingness-to-pay for disease-modifying therapies.
Frost N; Freeman J; Brixner D; Mort J; Clem J; Ngorsuraches S
Mult Scler Relat Disord; 2019 Oct; 35():55-60. PubMed ID: 31323483
[TBL] [Abstract][Full Text] [Related]
27. A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project.
Jimenez-Moreno AC; Pinto CA; Levitan B; Whichello C; Dyer C; Van Overbeeke E; de Bekker-Grob E; Smith I; Huys I; Viberg Johansson J; Adcock K; Bullock K; Soekhai V; Yuan Z; Lochmuller H; de Wit A; Gorman GS
Wellcome Open Res; 2020; 5():253. PubMed ID: 34395923
[No Abstract] [Full Text] [Related]
28. Quantifying preferences for asthma control in parents and adolescents using best-worst scaling.
Ungar WJ; Hadioonzadeh A; Najafzadeh M; Tsao NW; Dell S; Lynd LD
Respir Med; 2014 Jun; 108(6):842-51. PubMed ID: 24780719
[TBL] [Abstract][Full Text] [Related]
29. An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders' Risk Tolerance for Hip Replacement Surgery.
van Dijk JD; Groothuis-Oudshoorn CG; Marshall DA; IJzerman MJ
Value Health; 2016 Jun; 19(4):316-22. PubMed ID: 27325322
[TBL] [Abstract][Full Text] [Related]
30. Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.
dosReis S; Park A; Ng X; Frosch E; Reeves G; Cunningham C; Janssen EM; Bridges JFP
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):234-242. PubMed ID: 27991834
[TBL] [Abstract][Full Text] [Related]
31. Patient Preferences in the Treatment of Hemophilia A: A Best-Worst Scaling Case 3 Analysis.
Mühlbacher AC; Sadler A; Lamprecht B; Juhnke C
Value Health; 2020 Jul; 23(7):862-869. PubMed ID: 32762987
[TBL] [Abstract][Full Text] [Related]
32. What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China.
Liu S; Liu J; Yu Y; Si L; Tang C; Liu Z; Chen Y
Front Pharmacol; 2021; 12():802897. PubMed ID: 35002736
[No Abstract] [Full Text] [Related]
33. Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis.
Hollin IL; Peay HL; Bridges JF
Patient; 2015 Feb; 8(1):19-27. PubMed ID: 25523316
[TBL] [Abstract][Full Text] [Related]
34. Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy.
Hollin IL; Peay H; Fischer R; Janssen EM; Bridges JFP
Qual Life Res; 2018 Sep; 27(9):2261-2273. PubMed ID: 29804169
[TBL] [Abstract][Full Text] [Related]
35. A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis.
Bottomley C; Lloyd A; Bennett G; Adlard N
J Med Econ; 2017 Aug; 20(8):863-870. PubMed ID: 28562125
[TBL] [Abstract][Full Text] [Related]
36. Hemodialysis patients' preferences for the management of anemia.
Hauber B; Caloyeras J; Posner J; Brommage D; Tzivelekis S; Pollock A
BMC Nephrol; 2017 Jul; 18(1):253. PubMed ID: 28750609
[TBL] [Abstract][Full Text] [Related]
37. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.
Martínez-López I; Maurino J; Sanmartín-Fenollera P; Ontañon-Nasarre A; Santiago-Pérez A; Moya-Carmona I; García-Collado CG; Fernández-Del Olmo R; García-Arcelay E; Sarmiento M; Carreño Á; Pérez-Encinas M
Pharmacy (Basel); 2020 Apr; 8(2):. PubMed ID: 32272683
[No Abstract] [Full Text] [Related]
38. Patient preferences for treatment of metastatic melanoma.
Mansfield C; Ndife B; Chen J; Gallaher K; Ghate S
Future Oncol; 2019 Apr; 15(11):1255-1268. PubMed ID: 30694080
[TBL] [Abstract][Full Text] [Related]
39. Patient preferences for reducing bowel adverse events following prostate radiotherapy.
Mishra MV; Thayer WM; Janssen E; Hoppe B; Eggleston C; Bridges JFP
PLoS One; 2020; 15(7):e0235616. PubMed ID: 32639983
[TBL] [Abstract][Full Text] [Related]
40. Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm.
Ratcliffe J; Huynh E; Chen G; Stevens K; Swait J; Brazier J; Sawyer M; Roberts R; Flynn T
Soc Sci Med; 2016 May; 157():48-59. PubMed ID: 27060541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
